Loading…

Histone methylation‐mediated silencing of miR‐139 enhances invasion of non‐small‐cell lung cancer

MicroRNA expression is frequently altered in human cancers, and some microRNAs act as oncogenes or tumor suppressors. MiR‐139‐5p (denoted thereafter as miR‐139) has recently been reported to function as a tumor suppressor in several types of human cancer (hepatocellular carcinoma, colorectal cancer,...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2015-10, Vol.4 (10), p.1573-1582
Main Authors: Watanabe, Kousuke, Amano, Yosuke, Ishikawa, Rie, Sunohara, Mitsuhiro, Kage, Hidenori, Ichinose, Junji, Sano, Atsushi, Nakajima, Jun, Fukayama, Masashi, Yatomi, Yutaka, Nagase, Takahide, Ohishi, Nobuya, Takai, Daiya
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MicroRNA expression is frequently altered in human cancers, and some microRNAs act as oncogenes or tumor suppressors. MiR‐139‐5p (denoted thereafter as miR‐139) has recently been reported to function as a tumor suppressor in several types of human cancer (hepatocellular carcinoma, colorectal cancer, breast cancer, and gastric cancer), but its function in non‐small‐cell lung cancer (NSCLC) and the mechanism of its suppression have not been studied in detail. MiR‐139 was suppressed frequently in primary NSCLCs. MiR‐139 is located within the intron of PDE2A and its expression was significantly correlated with the expression of PDE2A. A chromatin immunoprecipitation assay revealed that miR‐139 was epigenetically silenced by histone H3 lysine 27 trimethylation (H3K27me3) of its host gene PDE2A and this process was independent of promoter DNA methylation. Pharmacological inhibition of both histone methylation and deacetylation‐induced miR‐139 with its host gene PDE2A. Ectopic expression of miR‐139 in lung cancer cell lines did not affect the proliferation nor the migration but significantly suppressed the invasion through the extracellular matrix. In primary NSCLCs, decreased expression of miR‐139 was significantly associated with distant lymph node metastasis and histological invasiveness (lymphatic invasion and vascular invasion) on both univariate and multivariate analyses. Collectively, these results suggest that H3K27me3‐mediated silencing of miR‐139 enhances an invasive and metastatic phenotype of NSCLC. miR‐139 was epigenetically silenced with its host gene PDE2A by histone H3 lysine 27 trimethylation (H3K27me3) in non‐small‐cell lung cancer. Ectopic expression of miR‐139 suppressed the invasion of lung cancer cells. Our results suggest that H3K27me3‐mediated silencing of miR‐139 may play a role in lung cancer metastasis.
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.505